Aaron K Salyapongse, MD
Orthopedic Surgery · Pleasanton
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
On the public record
- Owns San Ramon Surgery Center, LP: Accreditation Lapsed
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: 059145 · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Salyapongse’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A80294 · Current
Licensed to practise in California · since 2002 · expires 2028-03-31 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- San Ramon Surgery Center, LPAmbulatory Surgery Center · San Ramon, CA3.95% owner since 2007 · accredited by AAAHCAccreditation Lapsed2 inspections, 2 with deficiencies · last 2015-09-29: Requirements Met
- Pleasanton Surgery Center, LLCAmbulatory Surgery Center · Pleasanton, CA11.6% owner since 2018 · accredited by IMQAccreditation Renewed3 inspections, 2 with deficiencies · last 2018-07-23: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$334,759
Medicare paid this office $334,759 for 602 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 106 | $130,664 | $1,156 |
| Replacement of thigh bone and hip joint with prosthesis | 92 | $108,441 | $1,154 |
| Return visit (30+ min) | 358 | $46,233 | $112 |
| New patient visit (30+ min) | 144 | $14,121 | $98 |
| New patient visit (45+ min) | 53 | $6,992 | $132 |
See all 9 services
| Replacement of knee joint, both sides of knee | 106 | $130,664 | $1,156 |
| Replacement of thigh bone and hip joint with prosthesis | 92 | $108,441 | $1,154 |
| Return visit (30+ min) | 358 | $46,233 | $112 |
| New patient visit (30+ min) | 144 | $14,121 | $98 |
| New patient visit (45+ min) | 53 | $6,992 | $132 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 184 | $2,938 | $15 |
| Short return visit (20+ min) | 37 | $2,878 | $76 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,218 | $64 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $92 | None |
Procedures Medicare counted
| Hip replacement | 131 | More than 99% of doctors who do this |
| Knee replacement | 166 | More than 98% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
602 Original Medicare patients in 2024. Average age 74 · Under 65 2% · 85 and older 5% · Women 63% · Also on Medicaid 7% · Health risk score 0.84. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 68% · Chronic kidney disease 22% · Coronary heart disease 19% · Cancer 17% · Diabetes 16% · Atrial fibrillation 14% · Depression 14% · Heart failure 8% · COPD 8% · Stroke 5% · Dementia 2%.
The office billed $2,669,174, Medicare allowed $429,379 and paid $334,759; for 1,740 services of 28 kinds; $1,063 of it was for drugs given in the office and $333,696 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 602 | 1,740 | 74 | 0.84 | $2,669,174 | $334,759 |
| 2023 | 554 | 1,383 | 74 | 0.81 | $2,522,792 | $336,197 |
| 2022 | 573 | 3,180 | 74 | 0.84 | $2,633,704 | $361,241 |
| 2021 | 634 | 3,007 | 74 | 0.92 | $2,755,715 | $391,362 |
| 2020 | 663 | 11,315 | 75 | 1.00 | $1,959,229 | $390,017 |
| 2019 | 995 | 28,341 | 75 | 0.94 | $2,018,885 | $645,637 |
| 2018 | 885 | 22,301 | 74 | 0.96 | $2,206,535 | $547,164 |
| 2017 | 854 | 17,659 | 74 | 1.05 | $2,327,221 | $536,380 |
| 2016 | 795 | 7,789 | 73 | 1.03 | $1,911,634 | $424,404 |
| 2015 | 731 | 8,687 | 73 | 1.02 | $2,042,954 | $459,784 |
| 2014 | 611 | 6,941 | 73 | 0.99 | $1,989,513 | $420,842 |
| 2013 | 625 | 6,819 | 74 | 0.99 | $1,957,576 | $448,862 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Replacement of knee joint, both sides of knee | 119 | $148,632 | $1,170 |
| Replacement of thigh bone and hip joint with prosthesis | 70 | $83,094 | $1,170 |
| Return visit (30+ min) | 378 | $51,087 | $113 |
| Long return visit (40+ min) | 62 | $9,196 | $148 |
| New patient visit (45+ min) | 57 | $8,786 | $154 |
| New patient visit (30+ min) | 52 | $5,231 | $101 |
| Short return visit (20+ min) | 34 | $2,906 | $83 |
| Computer-assisted surgery for muscle and bone procedure | 18 | $2,304 | $128 |
| New patient visit (60+ min) | 12 | $1,681 | $140 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,602 | $67 |
| Telehealth originating site facility fee | 26 | $584 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $97 | None |
2022: 15 services
| Replacement of knee joint, both sides of knee | 115 | $143,114 | $1,164 |
| Replacement of thigh bone and hip joint with prosthesis | 71 | $82,556 | $1,163 |
| Return visit (30+ min) | 358 | $49,619 | $109 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 15 | $12,768 | None |
| Long return visit (40+ min) | 57 | $8,672 | $152 |
| New patient visit (45+ min) | 63 | $8,612 | $137 |
| New patient visit (60+ min) | 44 | $8,522 | $194 |
| Short return visit (20+ min) | 86 | $7,124 | $77 |
| New patient visit (30+ min) | 80 | $6,847 | $86 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 23 | $4,325 | $188 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 41 | $4,301 | $90 |
| Computer-assisted surgery for muscle and bone procedure | 20 | $2,664 | $127 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,574 | $58 |
| Telehealth originating site facility fee | 33 | $610 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | $308 | None |
2021: 13 services
| Replacement of knee joint, both sides of knee | 107 | $132,486 | $1,172 |
| Replacement of thigh bone and hip joint with prosthesis | 88 | $105,280 | $1,170 |
| Return visit (30+ min) | 373 | $57,213 | $115 |
| New patient visit (45+ min) | 84 | $11,215 | $134 |
| Long return visit (40+ min) | 71 | $11,167 | $157 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 78 | $9,801 | $99 |
| Short return visit (20+ min) | 99 | $9,514 | $80 |
| New patient visit (60+ min) | 49 | $9,276 | $189 |
| New patient visit (30+ min) | 105 | $8,811 | $84 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 12 | $2,244 | $187 |
| Aspiration and/or injection of fluid from large joint | 13 | $784 | $60 |
| Telehealth originating site facility fee | 34 | $729 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $637 | None |
2020: 20 services
| Replacement of knee joint, both sides of knee | 93 | $121,812 | $1,243 |
| Replacement of thigh bone and hip joint with prosthesis | 53 | $68,649 | $1,248 |
| Return visit (30+ min) | 454 | $65,143 | $93 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 35 | $40,976 | None |
| New patient visit (30+ min) | 172 | $15,698 | $91 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 110 | $14,101 | $96 |
| Short return visit (20+ min) | 106 | $7,651 | $64 |
| X-ray of knee, 3 views | 139 | $6,751 | $34 |
| X-ray of hip, 2-3 views | 70 | $2,689 | $38 |
| New patient visit (45+ min) | 15 | $2,145 | $143 |
| Mri scan of leg joint without contrast | 11 | $2,044 | $170 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,938 | $65 |
| X-ray of knee, 1-2 views | 43 | $1,698 | $32 |
| X-ray of both knees while standing | 42 | $1,696 | $39 |
| X-ray of pelvis, 1-2 views | 55 | $1,408 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | $860 | None |
| Short return visit | 14 | $578 | $39 |
| X-ray of both hips, 2 views | 22 | $236 | $10 |
| Telehealth originating site facility fee | 11 | $235 | $21 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $6 | None |
2019: 21 services
| Replacement of knee joint, both sides of knee | 108 | $139,510 | $1,213 |
| Replacement of thigh bone and hip joint with prosthesis | 81 | $108,700 | $1,235 |
| Return visit (30+ min) | 736 | $102,014 | $97 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 271 | $43,430 | $93 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 29 | $37,213 | None |
| X-ray of knee, 3 views | 366 | $24,422 | $37 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 62 | $24,384 | None |
| New patient visit (30+ min) | 231 | $21,996 | $95 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 19 | $20,279 | None |
| Short return visit (20+ min) | 227 | $18,172 | $67 |
| Mri scan of leg joint without contrast | 55 | $10,244 | $165 |
| X-ray of knee, 1-2 views | 245 | $9,982 | $32 |
| X-ray of hip, 2-3 views | 221 | $9,874 | $43 |
| X-ray of both knees while standing | 243 | $9,414 | $38 |
| X-ray of pelvis, 1-2 views | 197 | $9,191 | $33 |
| Removal of kneecap | 12 | $4,251 | $354 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 169 | $2,339 | None |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 19 | $2,230 | $68 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 29 | $1,583 | $49 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,043 | $58 |
| X-ray of both hips, 2 views | 83 | $932 | $10 |
2018: 24 services
| Replacement of knee joint, both sides of knee | 110 | $144,723 | $1,206 |
| Replacement of thigh bone and hip joint with prosthesis | 69 | $86,935 | $1,207 |
| Return visit (30+ min) | 549 | $68,574 | $93 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 244 | $33,447 | $85 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 30 | $28,673 | None |
| New patient visit (30+ min) | 219 | $19,614 | $90 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 29 | $18,443 | None |
| X-ray of knee, 3 views | 272 | $16,211 | $35 |
| Mri scan of leg joint without contrast | 83 | $16,007 | $160 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 17 | $10,474 | None |
| Short return visit (20+ min) | 147 | $10,234 | $59 |
| X-ray of knee, 1-2 views | 252 | $9,337 | $29 |
| X-ray of both knees while standing | 248 | $8,801 | $35 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 138 | $7,931 | $50 |
| Removal of kneecap | 26 | $7,759 | $298 |
| X-ray of pelvis, 1-2 views | 184 | $6,990 | $29 |
| X-ray of hip, 2-3 views | 158 | $6,754 | $40 |
| Mri scan of lower spinal canal without contrast | 24 | $3,491 | $145 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 175 | $2,400 | None |
| Short return visit | 40 | $1,705 | $41 |
| X-ray of both hips, 2 views | 68 | $721 | $10 |
| Aspiration and/or injection of fluid from large joint | 11 | $696 | $58 |
| X-ray of both hips, 2 views | 18 | $639 | $35 |
| Injection, dexamethasone sodium phosphate, 1 mg | 19 | $5 | None |
2017: 24 services
| Replacement of knee joint, both sides of knee | 94 | $117,638 | $1,165 |
| Replacement of thigh bone and hip joint with prosthesis | 71 | $87,276 | $1,164 |
| Return visit (30+ min) | 514 | $62,908 | $85 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 240 | $35,694 | $82 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 52 | $35,563 | None |
| New patient visit (30+ min) | 216 | $18,561 | $86 |
| Mri scan of leg joint without contrast | 86 | $16,832 | $170 |
| X-ray of both knees while standing | 373 | $15,922 | $33 |
| X-ray of knee, 1-2 views | 372 | $15,595 | $27 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 13 | $14,464 | None |
| Short return visit (20+ min) | 180 | $13,070 | $61 |
| X-ray of pelvis, 1-2 views | 275 | $11,127 | $29 |
| Removal of kneecap | 24 | $7,153 | $286 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 11 | $6,308 | None |
| X-ray of knee, 3 views | 120 | $5,232 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 192 | $3,402 | None |
| Aspiration and/or injection of fluid from large joint | 47 | $3,172 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,256 | $174 |
| X-ray of hip, 2-3 views | 60 | $2,193 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 30 | $1,514 | $49 |
| X-ray of both hips, 2 views | 71 | $762 | $10 |
| X-ray of both hips, 2 views | 13 | $457 | $35 |
| Short return visit | 11 | $399 | $36 |
| Injection, dexamethasone sodium phosphate, 1 mg | 22 | $5 | None |
2016: 22 services
| Replacement of knee joint, both sides of knee | 70 | $84,787 | $1,146 |
| Replacement of thigh bone and hip joint with prosthesis | 58 | $69,456 | $1,139 |
| Return visit (30+ min) | 513 | $66,034 | $88 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 203 | $28,739 | $82 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 26 | $17,511 | None |
| New patient visit (30+ min) | 195 | $16,833 | $86 |
| X-ray of both knees while standing | 349 | $16,166 | $33 |
| X-ray of knee, 1-2 views | 349 | $15,629 | $27 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 20 | $13,604 | None |
| Mri scan of leg joint without contrast | 74 | $13,479 | $160 |
| Short return visit (20+ min) | 149 | $9,974 | $60 |
| X-ray of pelvis, 1-2 views | 210 | $8,527 | $28 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 15 | $7,789 | None |
| Removal of kneecap | 27 | $7,596 | $281 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 184 | $3,229 | None |
| Aspiration and/or injection of fluid from large joint | 40 | $2,746 | $53 |
| X-ray of hip, 2-3 views | 57 | $2,103 | $37 |
| Mri scan of lower spinal canal without contrast | 12 | $1,712 | $143 |
| X-ray of hip, 1 view | 33 | $820 | $25 |
| X-ray of both hips, 2 views | 57 | $594 | $10 |
| X-ray of both hips, 2 views | 15 | $552 | $37 |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $2 | None |
2015: 25 services
| Replacement of knee joint, both sides of knee | 84 | $100,119 | $1,164 |
| Replacement of thigh bone and hip joint with prosthesis | 65 | $83,075 | $1,170 |
| Return visit (30+ min) | 494 | $66,834 | $87 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 37 | $28,793 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 182 | $23,928 | $87 |
| New patient visit (30+ min) | 166 | $14,255 | $86 |
| X-ray of knee, 1-2 views | 291 | $12,782 | $26 |
| X-ray of both knees while standing | 291 | $12,776 | $30 |
| Mri scan of leg joint without contrast | 51 | $11,381 | $196 |
| X-ray of pelvis, 1-2 views | 233 | $8,245 | $25 |
| Removal of kneecap | 29 | $7,790 | $269 |
| Short return visit (20+ min) | 115 | $7,683 | $61 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 18 | $7,237 | None |
| Aspiration and/or injection of fluid from large joint | 98 | $5,071 | $41 |
| X-ray of ribs of one side of body, minimum of 2 views | 113 | $4,317 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 189 | $2,864 | None |
| Ultrasonic guidance for needle placement | 59 | $2,832 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,753 | $172 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 19 | $909 | $48 |
| X-ray of knee, 4 or more views | 14 | $681 | $36 |
| X-ray of both hips minimum 2 views | 53 | $644 | $12 |
| X-ray of hip on one side of body, 1 view | 21 | $533 | $24 |
| X-ray of knee, 3 views | 11 | $350 | $32 |
| X-ray for bone length assessment | 11 | $137 | $12 |
| Injection, dexamethasone sodium phosphate, 1 mg | 16 | $3 | None |
2014: 24 services
| Replacement of knee joint, both sides of knee | 75 | $92,237 | $1,198 |
| Replacement of thigh bone and hip joint with prosthesis | 55 | $64,665 | $1,176 |
| Return visit (30+ min) | 454 | $63,191 | $89 |
| Aspiration and/or injection of fluid from large joint | 191 | $17,658 | $47 |
| Ultrasonic guidance for needle placement | 148 | $16,032 | $66 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 25 | $15,726 | None |
| X-ray of knee, 1-2 views | 275 | $14,346 | $29 |
| X-ray of both knees while standing | 273 | $13,802 | $33 |
| New patient visit (30+ min) | 123 | $10,495 | $85 |
| Mri scan of leg joint without contrast | 50 | $9,800 | $181 |
| X-ray of pelvis, 1-2 views | 229 | $9,619 | $26 |
| Removal of kneecap | 29 | $8,611 | $297 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 22 | $8,441 | None |
| Short return visit (20+ min) | 98 | $6,142 | $58 |
| X-ray of ribs of one side of body, minimum of 2 views | 121 | $5,286 | $37 |
| Stabilization of upper thigh bone with device | 11 | $4,822 | $438 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 148 | $2,129 | None |
| X-ray of knee, 4 or more views | 16 | $775 | $39 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $570 | $48 |
| X-ray of hip on one side of body, 1 view | 17 | $437 | $26 |
| Short return visit | 11 | $435 | $40 |
| X-ray for bone length assessment | 17 | $218 | $13 |
| X-ray of ribs of one side of body, minimum of 2 views | 17 | $167 | $10 |
| Injection, dexamethasone sodium phosphate, 1 mg | 27 | $16 | None |
2013: 22 services
| Replacement of knee joint, both sides of knee | 53 | $70,673 | $1,285 |
| Ultrasonic guidance for needle placement | 189 | $67,180 | $195 |
| Replacement of thigh bone and hip joint with prosthesis | 55 | $66,835 | $1,193 |
| Return visit (30+ min) | 392 | $49,033 | $85 |
| Aspiration and/or injection of fluid from large joint | 203 | $17,152 | $45 |
| X-ray of knee, 1-2 views | 276 | $14,167 | $28 |
| X-ray of both knees while standing | 281 | $13,996 | $33 |
| New patient visit (30+ min) | 148 | $13,260 | $90 |
| Removal of kneecap | 43 | $12,739 | $283 |
| X-ray of pelvis, 1-2 views | 247 | $10,826 | $26 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 17 | $10,551 | None |
| Short return visit (20+ min) | 141 | $9,015 | $57 |
| X-ray of ribs of one side of body, minimum of 2 views | 154 | $7,009 | $36 |
| Mri scan of leg joint without contrast | 34 | $6,847 | $196 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 32 | $4,003 | $121 |
| Mri scan of lower spinal canal without contrast | 11 | $3,686 | $335 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 186 | $2,641 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,435 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,818 | $107 |
| X-ray of thigh, 2 views | 11 | $807 | $25 |
| X-ray of lower and sacral spine, 2-3 views | 15 | $514 | $34 |
| Short return visit | 11 | $434 | $39 |
Drugs they prescribed that Part D paid
$1,735
Pharmacies billed $1,735 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 28% of their Part D prescriptions (22 of 78) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
75 generic and fewer than 11 brand-name prescriptions · $1,735 in drug cost · 14 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 12 | $485 | $30 |
| Oxycodone | 12 | $78 | $7 |
| Amoxicillin | 11 | $15 | $1 |
Year by year
| 2024 | 78 | 60 | 28% (22) | None | $1,735 |
| 2023 | 95 | 63 | 31% (29) | None | $1,976 |
| 2022 | 110 | 71 | 21% (23) | None | $2,032 |
| 2021 | 129 | 86 | 21% (27) | None | $2,352 |
| 2020 | 441 | 181 | 29% (127) | 7% | $12,134 |
| 2019 | 642 | 268 | 34% (218) | 4% | $17,467 |
| 2018 | 803 | 286 | 26% (210) | 5% | $26,860 |
| 2017 | 850 | 288 | 32% (268) | 7% | $38,766 |
| 2016 | 594 | 248 | 25% (149) | 10% | $28,530 |
| 2015 | 559 | 239 | 43% (240) | 12% | $31,987 |
| 2014 | 478 | 214 | 43% (207) | 14% | $27,475 |
| 2013 | 528 | 207 | 38% (201) | 15% | $40,153 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Celecoxib | 16 | $611 | $38 |
| Hydrocodone-Acetaminophen | 13 | $155 | $12 |
| Amoxicillin | 12 | $45 | $4 |
2022: 4 drugs
| Celecoxib | 21 | $775 | $37 |
| Hydrocodone-Acetaminophen | 13 | $180 | $14 |
| Meloxicam | 14 | $39 | $3 |
| Amoxicillin | 11 | $38 | $3 |
2021: 5 drugs
| Celecoxib | 33 | $999 | $30 |
| Etodolac | 11 | $302 | $27 |
| Hydrocodone-Acetaminophen | 16 | $152 | $9 |
| Meloxicam | 15 | $50 | $3 |
| Amoxicillin | 13 | $42 | $3 |
2020: 8 drugs
| Enoxaparin | 55 | $4,400 | $80 |
| Celecoxib | 120 | $3,082 | $26 |
| Diclofenac | 26 | $1,023 | $39 |
| Hydrocodone-Acetaminophen | 68 | $737 | $11 |
| Oxycodone-Acetaminophen | 21 | $263 | $13 |
| Meloxicam | 17 | $123 | $7 |
| Tramadol | 29 | $115 | $4 |
| Amoxicillin | 32 | $88 | $3 |
2019: 12 drugs
| Enoxaparin | 70 | $5,535 | $79 |
| Celecoxib | 113 | $2,839 | $25 |
| Diclofenac | 44 | $2,095 | $48 |
| Hydrocodone-Acetaminophen | 113 | $1,800 | $16 |
| Oxycodone-Acetaminophen | 40 | $1,216 | $30 |
| Etodolac | 14 | $897 | $64 |
| Cyclobenzaprine | 15 | $237 | $16 |
| Amoxicillin | 60 | $205 | $3 |
| Tramadol | 53 | $159 | $3 |
| Meloxicam | 22 | $123 | $6 |
| Naproxen | 15 | $103 | $7 |
| Omeprazole | 11 | $66 | $6 |
2018: 15 drugs
| Celecoxib | 157 | $8,467 | $54 |
| Enoxaparin | 113 | $8,137 | $72 |
| Hydrocodone-Acetaminophen | 104 | $1,830 | $18 |
| Diclofenac | 46 | $1,268 | $28 |
| Oxycodone-Acetaminophen | 27 | $838 | $31 |
| Etodolac | 17 | $805 | $47 |
| Amoxicillin | 83 | $260 | $3 |
| Oxycodone | 13 | $234 | $18 |
| Tramadol | 50 | $178 | $4 |
| Gabapentin | 12 | $139 | $12 |
| Acetaminophen-Codeine | 12 | $131 | $11 |
| Meloxicam | 37 | $116 | $3 |
| Naproxen | 11 | $104 | $9 |
| Omeprazole | 17 | $87 | $5 |
| Clindamycin | 11 | $62 | $6 |
2017: 10 drugs
| Enoxaparin | 137 | $13,121 | $96 |
| Celecoxib | 174 | $8,819 | $51 |
| Hydrocodone-Acetaminophen | 134 | $2,122 | $16 |
| Oxycodone-Acetaminophen | 52 | $1,902 | $37 |
| Etodolac | 21 | $792 | $38 |
| Diclofenac | 31 | $564 | $18 |
| Amoxicillin | 89 | $304 | $3 |
| Tramadol | 53 | $292 | $6 |
| Acetaminophen-Codeine | 14 | $185 | $13 |
| Meloxicam | 17 | $62 | $4 |
2016: 10 drugs
| Enoxaparin | 101 | $12,809 | $127 |
| Celecoxib | 82 | $4,288 | $52 |
| Xarelto | 12 | $3,088 | $257 |
| Hydrocodone-Acetaminophen | 76 | $1,954 | $26 |
| Oxycodone-Acetaminophen | 28 | $1,327 | $47 |
| Etodolac | 24 | $1,122 | $47 |
| Diclofenac | 28 | $751 | $27 |
| Amoxicillin | 88 | $273 | $3 |
| Meloxicam | 32 | $153 | $5 |
| Tramadol | 32 | $148 | $5 |
2015: 12 drugs
| Enoxaparin | 70 | $15,139 | $216 |
| Celecoxib | 34 | $3,718 | $109 |
| Hydrocodone-Acetaminophen | 117 | $2,897 | $25 |
| Oxycodone-Acetaminophen | 46 | $2,470 | $54 |
| Voltaren | 15 | $1,286 | $86 |
| Etodolac | 22 | $1,067 | $49 |
| Tramadol | 58 | $307 | $5 |
| Amoxicillin | 79 | $230 | $3 |
| Acetaminophen-Codeine | 12 | $183 | $15 |
| Ibuprofen | 13 | $115 | $9 |
| Meloxicam | 15 | $71 | $5 |
| Clindamycin | 15 | $64 | $4 |
2014: 10 drugs
| Enoxaparin | 45 | $10,466 | $233 |
| Celebrex | 23 | $4,568 | $199 |
| Hydrocodone-Acetaminophen | 146 | $3,098 | $21 |
| Lidocaine-Prilocaine | 14 | $1,890 | $135 |
| Voltaren | 18 | $1,228 | $68 |
| Oxycodone-Acetaminophen | 12 | $890 | $74 |
| Diclofenac | 30 | $491 | $16 |
| Tramadol | 27 | $161 | $6 |
| Amoxicillin | 44 | $159 | $4 |
| Meloxicam | 26 | $146 | $6 |
2013: 10 drugs
| Enoxaparin | 69 | $22,233 | $322 |
| Celebrex | 33 | $7,423 | $225 |
| Hydrocodone-Acetaminophen | 144 | $2,429 | $17 |
| Oxycodone Hcl-Acetaminophen | 15 | $633 | $42 |
| Meloxicam | 64 | $536 | $8 |
| Etodolac | 15 | $306 | $20 |
| Diclofenac | 12 | $210 | $17 |
| Amoxicillin | 37 | $147 | $4 |
| Tramadol | 15 | $102 | $7 |
| Ibuprofen | 12 | $99 | $8 |
Money from drug and device companies
$20,954 in 2025
| 2025 | 4 | 22 | $19,688 | $20,954 |
| 2024 | 4 | 27 | $13,775 | $24,009 |
| 2023 | 6 | 43 | $51,295 | $64,927 |
| 2022 | 6 | 24 | $257,466 | $258,776 |
| 2021 | 6 | 46 | $37,245 | $39,026 |
| 2020 | 2 | 42 | $26,393 | $28,093 |
| 2019 | 5 | 32 | $21,348 | $22,243 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $20,662 | 19 payments
|
| Zimmer Biomet Holdings | None | $182 | 1 payment
|
| Pixee Medical | None | $89 | 1 payment
|
| Medical Device Business Services | Attune | $21 | 1 payment
|
See all 22 published payments
| MicroPort Orthopedics | Consulting · 2025-12-23 | Mpo Medial Pivot Knee | $713 |
| Zimmer Biomet Holdings | Meals · 2025-10-30 | None | $182 |
| MicroPort Orthopedics | Meals · 2025-10-02 | Mpo Hip System | $12 |
| MicroPort Orthopedics | Meals · 2025-10-02 | Mpo Hip System | $97 |
| MicroPort Orthopedics | Meals · 2025-07-23 | Mpo Hip System | $13 |
| MicroPort Orthopedics | Consulting · 2025-05-28 | Mpo Medial Pivot Knee | $3,000 |
| MicroPort Orthopedics | Consulting · 2025-05-28 | Mpo Medial Pivot Knee | $3,800 |
| Pixee Medical | Meals · 2025-05-08 | None | $89 |
| MicroPort Orthopedics | Paid to speak or teach · 2025-04-16 | Mpo Medial Pivot Knee | $1,425 |
| MicroPort Orthopedics | Paid to speak or teach · 2025-04-16 | Mpo Medial Pivot Knee | $1,425 |
| Medical Device Business Services | Meals · 2025-03-20 | Attune | $21 |
| MicroPort Orthopedics | Travel · 2025-03-16 | Mpo Medial Pivot Knee | $25 |
| MicroPort Orthopedics | Meals · 2025-03-15 | Mpo Medial Pivot Knee | $11 |
| MicroPort Orthopedics | Meals · 2025-03-15 | Mpo Medial Pivot Knee | $49 |
| MicroPort Orthopedics | Meals · 2025-03-15 | Mpo Medial Pivot Knee | $74 |
| MicroPort Orthopedics | Travel · 2025-03-15 | Mpo Medial Pivot Knee | $96 |
| MicroPort Orthopedics | Travel · 2025-03-14 | Mpo Medial Pivot Knee | $269 |
| MicroPort Orthopedics | Consulting · 2025-02-26 | Mpo Medial Pivot Knee | $950 |
| MicroPort Orthopedics | Travel · 2025-02-03 | Mpo Medial Pivot Knee | $167 |
| MicroPort Orthopedics | Meals · 2025-01-24 | Mpo Medial Pivot Knee | $160 |
| MicroPort Orthopedics | Consulting · 2025-01-08 | Mpo Medial Pivot Knee | $2,375 |
| MicroPort Orthopedics | Consulting · 2025-01-08 | Mpo Medial Pivot Knee | $6,000 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $24,009
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $23,812 | 23 payments
|
| Kyocera Medical Technologies | None | $156 | 1 payment
|
| Medtronic | Aquamantys(Tm) | $24 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $17 | 1 payment
|
2023: $64,927
| Kyocera Medical Technologies | None | $47,637 | 3 payments
|
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $14,389 | 28 payments
|
| Medical Device Business Services | None | $2,633 | 1 payment
|
| Innovation Technologies | Irrisept | $115 | 1 payment
|
| DePuy Synthes Sales | Inhance | $106 | 1 payment
|
| Heron Therapeutics | Zynrelef | $48 | 2 payments
|
2022: $258,776
| DePuy Synthes Products | None | $220,000 | 1 payment
|
| Kyocera Medical Technologies | None | $24,373 | 2 payments
|
| Medical Device Business Services | None | $10,958 | 8 payments
|
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $3,316 | 6 payments
|
| DePuy Synthes Sales | Velys | $117 | 1 payment
|
| Heraeus Medical | Palacos | $11 | 1 payment
|
2021: $39,026
| Medical Device Business Services | Attune | $19,694 | 15 payments
|
| DePuy Synthes Products | None | $13,690 | 14 payments
|
| MicroPort Orthopedics | Mpo Hip System | $4,440 | 8 payments
|
| Kyocera Medical Technologies | None | $869 | 1 payment
|
| DePuy Synthes Sales | Velys | $245 | 4 payments
|
| Zimmer Biomet Holdings | Arcos | $88 | 2 payments
|
2020: $28,093
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $16,378 | 26 payments
|
| Medical Device Business Services | Attune | $11,714 | 16 payments
|
2019: $22,243
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $14,051 | 24 payments
|
| DePuy Synthes Products | Attune | $5,446 | 4 payments
|
| Medical Device Business Services | Attune | $2,700 | 2 payments
|
| DePuy Synthes Sales | None | $26 | 1 payment
|
| Mallinckrodt Enterprises | Ofirmev | $20 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
Professional record
- NPI
- 1598711681
- Licence
- CA A80294, MA 227085California A80294: Current · expires 2028-03-31
- Trained
- Saint Louis University School of Medicine, 2001
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XS0114X (207XS0114X); Orthopedic surgery (207X00000X)
- Mailing address
- 300 Pasteur Dr Ste 215, Stanford, CA, 94305
- NPI first listed
- 2006-05-26
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.